Fentanyl sublingual spray for breakthrough cancer pain in patients receiving transdermal fentanyl
Aim: To investigate the relationship between effective fentanyl sublingual spray (FSS) doses for breakthrough cancer pain (BTCP) and around-the-clock (ATC) transdermal fentanyl patch (TFP). Methods: Adults tolerating ATC opioids received open-label FSS for 26 days, followed by a 26-day double-blind...
| Main Authors: | , , , |
|---|---|
| Other Authors: | |
| Language: | en |
| Published: |
FUTURE MEDICINE LTD
2016
|
| Subjects: | |
| Online Access: | http://hdl.handle.net/10150/621765 http://arizona.openrepository.com/arizona/handle/10150/621765 |